Clinical Trial Update: Prognosis Stratification for Advanced HCC Receiving TACE with PD-1/PD-L1 Inhibitors and Molecular Target Therapies

View source ↗

Summary

This clinical trial update shows a recruiting study at Zhongda Hospital evaluating prognosis-based stratification for advanced hepatocellular carcinoma treated …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Zhongda Hospital | Conditions: Hepatocellular Carcinoma | Status: RECRUITING